| Pilot Study of MC in Paediatric Palliative Care (NCT05615389) | Murdoch Childrens Research Institute | 2024-02-19 |
| A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. (NCT06206837) | Pfizer | 2024-02-19 |
| Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) (NCT05483010) | Washington University School of Medicine | 2024-02-19 |
| A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT07065032) | Beijing QL Biopharmaceutical Co.,Ltd | 2024-02-19 |
| Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib (NCT06206850) | Jair Bar, M.D., Ph.D. | 2024-02-19 |
| Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab (NCT06237920) | The Netherlands Cancer Institute | 2024-02-19 |
| A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease (NCT06088979) | Tourmaline Bio, Inc., a Novartis Company | 2024-02-19 |
| Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria (NCT06298955) | Omeros Corporation | 2024-02-19 |
| Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia (NCT05537896) | West Virginia University | 2024-02-19 |
| Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer (NCT05904080) | National Cancer Institute (NCI) | 2024-02-19 |
| FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial (NCT06244004) | Northwestern University | 2024-02-18 |
| Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy (NCT06279754) | The First Affiliated Hospital of Xinxiang Medical College | 2024-02-18 |
| Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia (NCT06585345) | The General Hospital of Western Theater Command | 2024-02-18 |
| Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease (NCT06317675) | Studio Osteopatico Busto Arsizio | 2024-02-18 |
| mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria (NCT06607107) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-02-17 |
| DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment (NCT06075953) | QuantumLeap Healthcare Collaborative | 2024-02-17 |
| ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function (NCT05907096) | argenx | 2024-02-17 |
| Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma (NCT06304350) | Tongji University | 2024-02-17 |
| A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (NCT05901519) | University of Michigan Rogel Cancer Center | 2024-02-16 |
| PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC (NCT06239220) | Dana-Farber Cancer Institute | 2024-02-16 |
| Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer (NCT05756166) | Roswell Park Cancer Institute | 2024-02-16 |
| Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer (NCT06014255) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-02-16 |
| Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma (NCT06278545) | Centre Hospitalier Universitaire Dijon | 2024-02-16 |
| INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 (NCT05703555) | Erasmus Medical Center | 2024-02-16 |
| A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery (NCT06220123) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2024-02-16 |
| Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers (NCT06085716) | M.D. Anderson Cancer Center | 2024-02-16 |
| RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus (NCT06121297) | Cabaletta Bio | 2024-02-16 |
| The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions. (NCT07391306) | JSC NextGen | 2024-02-16 |
| Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy (NCT06051240) | Region Stockholm | 2024-02-16 |
| Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib (NCT06120140) | Janssen Research & Development, LLC | 2024-02-16 |
| Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A (NCT06314490) | University of California, San Diego | 2024-02-16 |
| Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma (NCT06112522) | Centre Hospitalier Universitaire de Nice | 2024-02-16 |
| A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (NCT06097663) | Novartis Pharmaceuticals | 2024-02-15 |
| A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer (NCT06211023) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-02-15 |
| Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer (NCT06161506) | National Cancer Institute (NCI) | 2024-02-15 |
| Open-Label of SPN-820 in Adults With Major Depressive Disorder (NCT06235905) | Navitor Pharmaceuticals, Inc. | 2024-02-15 |
| Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients (NCT06394011) | The First Affiliated Hospital of Soochow University | 2024-02-15 |
| The Herbal Acupoint Patch for Dialysis Patient With Fistula-related Pain (NCT07380581) | Chang Gung Memorial Hospital | 2024-02-15 |
| CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma (NCT06482684) | Christian Schmidt, MD | 2024-02-15 |
| Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer (NCT06255262) | China Medical University, China | 2024-02-15 |
| [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer (NCT05898854) | Aalborg University Hospital | 2024-02-15 |
| Surgical Release of Hand Tendons with Wrapping of the Released Tendon Using an Amniotic Membrane (NCT06723782) | TBF Genie Tissulaire | 2024-02-15 |
| Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis (NCT04858009) | Mayo Clinic | 2024-02-15 |
| Nodular Shrinking in Dupuytren Disease (NCT06321991) | Universitaire Ziekenhuizen KU Leuven | 2024-02-15 |
| Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis (NCT05145816) | University of Texas Southwestern Medical Center | 2024-02-15 |
| HRD Tests for Ovarian cancER (NCT06152731) | Centre Francois Baclesse | 2024-02-15 |
| A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer (NCT06255964) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2024-02-15 |
| A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) (NCT06153095) | Lyell Immunopharma, Inc. | 2024-02-15 |
| Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis (NCT06225843) | Alethia Biotherapeutics | 2024-02-15 |
| Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis (NCT05708430) | University Hospital, Rouen | 2024-02-15 |
| Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06281886) | Sun Yat-sen University | 2024-02-15 |
| A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients (NCT05753007) | Mclean Hospital | 2024-02-15 |
| Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) (NCT06182085) | PRInnovation GmbH | 2024-02-15 |
| Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy (NCT06958445) | Taipei City Hospital | 2024-02-15 |
| 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy (NCT05483023) | UNC Lineberger Comprehensive Cancer Center | 2024-02-15 |
| Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients (NCT06279793) | GCP-Service International West GmbH | 2024-02-15 |
| Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder (NCT06160232) | Brugmann University Hospital | 2024-02-15 |
| A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK (NCT06269484) | AstraZeneca | 2024-02-15 |
| Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2) (NCT05797870) | Center Eugene Marquis | 2024-02-14 |
| Open Label Extension Study of Brentuximab Vedotin in Early dcSSc (NCT05149768) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2024-02-14 |
| Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock (NCT05969275) | Ottawa Hospital Research Institute | 2024-02-14 |
| Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice (NCT06236165) | Tanta University | 2024-02-14 |
| Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer (NCT06140407) | Vanderbilt-Ingram Cancer Center | 2024-02-14 |
| 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH) (NCT04941599) | Vanderbilt University Medical Center | 2024-02-14 |
| A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia (NCT05635344) | Imperial College London | 2024-02-14 |
| Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer (NCT05783323) | Children's Hospital of Philadelphia | 2024-02-14 |
| Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma (NCT05998642) | Canadian Cancer Trials Group | 2024-02-13 |
| Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2 (NCT05850247) | Hospices Civils de Lyon | 2024-02-13 |
| Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors (NCT06234098) | Alyssum Therapeutics | 2024-02-13 |
| Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF) (NCT06215586) | Cardurion Pharmaceuticals, Inc. | 2024-02-13 |
| A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer (NCT06016270) | STCube, Inc. | 2024-02-13 |
| A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF) (NCT06215911) | Cardurion Pharmaceuticals, Inc. | 2024-02-13 |
| Sleep Health Enhancement in Midlife Adults (NCT06311500) | University of Kansas Medical Center | 2024-02-13 |
| The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome) (NCT05237505) | University of California, San Diego | 2024-02-13 |
| Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis (NCT05630872) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-02-13 |
| A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE (NCT06040099) | AstraZeneca | 2024-02-13 |
| MDMA Plus Exposure Therapy for PTSD (NCT05746572) | Emory University | 2024-02-13 |
| Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio (NCT05655949) | Beth Israel Deaconess Medical Center | 2024-02-13 |
| HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) (NCT06313203) | Oslo University Hospital | 2024-02-13 |
| Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia (NCT05386394) | Johns Hopkins University | 2024-02-13 |
| Tocilizumab in Lung Transplantation (NCT06033196) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-02-13 |
| Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma (NCT05929495) | University of Milano Bicocca | 2024-02-12 |
| Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence (NCT05952934) | University of Arkansas | 2024-02-12 |
| MIVetsCan: Cannabidiol (CBD)-Care Trial (NCT06213233) | Kevin Boehnke | 2024-02-12 |
| Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM) (NCT05525572) | University of Miami | 2024-02-12 |
| A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors (NCT06244771) | Frontier Medicines Corporation | 2024-02-12 |
| Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC) (NCT05374915) | Kintara Therapeutics, Inc. | 2024-02-12 |
| Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction (NCT06241742) | Halia Therapeutics, Inc. | 2024-02-12 |
| Prophylactic Tributyrin Supplementation in Acute Pancreatitis (NCT06147635) | St. Antonius Hospital | 2024-02-12 |
| Descartes-08 for Patients With Systemic Lupus Erythematosus (NCT06038474) | Cartesian Therapeutics | 2024-02-12 |
| Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (NCT06159166) | Johns Hopkins University | 2024-02-12 |
| DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) (NCT06027086) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-02-12 |
| RecoverPC: Relugolix vs GnRH Agonist in Quality of Life (NCT05765500) | Dana-Farber Cancer Institute | 2024-02-12 |
| Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera (NCT06193408) | Hunazine Biotech S.L. | 2024-02-11 |
| Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer (NCT06236997) | Henan Cancer Hospital | 2024-02-10 |
| Noninvasive Modulation of Chronic Neuropathic Pain (NCT06249724) | University of Utah | 2024-02-10 |
| Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT06259721) | Jiangxi Provincial Cancer Hospital | 2024-02-10 |
| Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer (NCT06202313) | Shengjing Hospital | 2024-02-10 |
| Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) (NCT05564403) | National Cancer Institute (NCI) | 2024-02-09 |
| Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma (NCT06211114) | Peking University Cancer Hospital & Institute | 2024-02-09 |